Following H5N1 avian influenza's spread into dairy cattle populations and the resulting human cases, clinical and public health laboratories have continued building out surveillance testing capacity and readiness protocols specifically for this pathogen, applying hard-won lessons from pandemic-era testing scale-up to a more proactive, earlier-stage preparedness effort this time around.
What's Been Built Since the Outbreak Began
- Expanded reference laboratory testing capacity beyond the small number of specialized public health labs that originally handled H5N1 testing exclusively, distributing capability more broadly across the clinical laboratory network
- Clearer clinical testing algorithms helping frontline clinicians identify which patients warrant H5N1-specific testing versus standard seasonal influenza testing, avoiding both under-testing of genuine risk cases and unnecessary strain on specialized testing capacity
- Supply chain pre-positioning for specialized reagents and PPE specific to H5N1 handling protocols, informed directly by the supply strain experienced during earlier pandemic-scale testing ramp-up
Why Proactive Readiness Matters Here
Unlike the initial COVID-19 emergence, where testing infrastructure had to be built essentially from scratch under acute time pressure, the current H5N1 situation has allowed labs meaningful lead time to build capacity proactively — a genuinely different and more favorable starting position, assuming that lead time is actually used effectively before any potential broader spread.
What Facilities Should Have Ready
Facilities should confirm their lab has a clear, current protocol for H5N1 testing referral and specimen handling, along with appropriate PPE stock for staff handling suspected cases, rather than assuming existing seasonal influenza protocols are automatically sufficient for this distinct pathogen.
Facilities building surveillance testing readiness can review Healix Medical Supply's lab supplies catalog and infection control catalog.
